Abstract: A mooring system (10) for use in mooring a marine device (24) within a fluid (12) subject to flow comprises a mooring line (16) to be secured to an anchor (18) and defining a tether point for a marine device (24), and a loading assembly (20) secured to the mooring line (16) and configured to generate hydrodynamic lift when exposed to flow to apply tension to the mooring line (16). In embodiments of the invention the loading assembly (20) is configured to also generate a buoyancy force, such that tension is applied to the mooring line (16) by a combination of the hydrodynamic lift force and the buoyancy force.

Abstract: A mooring system (10) for use in mooring a marine device (24) within a fluid (12) subject to flow comprises a mooring line (16) to be secured to an anchor (18) and defining a tether point for a marine device (24), and a loading assembly (20) secured to the mooring line (16) and configured to generate hydrodynamic lift when exposed to flow to apply tension to the mooring line (16). In embodiments of the invention the loading assembly (20) is configured to also generate a buoyancy force, such that tension is applied to the mooring line (16) by a combination of the hydrodynamic lift force and the buoyancy force.

Abstract: A turbine (5) having at least two sets of co-axially mounted, rotatable blades (10, 15) arranged so that one set cannot eclipse another. Preferably, the sets of blades (10, 15) are contra-rotatable. Each set of blades (10, 15) may be operable to extract similar amounts of energy, thereby to minimise the net reactive torque.

Abstract: A turbine (5) having at least two sets of co-axially mounted, rotatable blades (10, 15) arranged so that one set cannot eclipse another. Preferably, the sets of blades (10, 15) are contra-rotatable. Each set of blades (10, 15) may be operable to extract similar amounts of energy, thereby to minimise the net reactive torque.

Abstract: This invention relates to isolated proteins and to peptides which are found on the surface of colon cells and colon cancer cells, as well as to nucleic acid molecules encoding said protein and peptides. The protein and peptides bind to tumor associated antibodies, such as mAb 33. The monomeric protein has a molecular weight of about 43 kD as determined by SDS gel electrophoresis under non-reducing conditions. In addition, this invention relates to the use of said nucleic acid molecules, protein, in monomeric or multimeric form, and to antibodies to said peptides in diagnostic, screening and therapeutic methods. This invention further relates to antibodies specific for said protein, in monomeric or multimeric form, and to antibodies to said peptides.

Abstract: This invention relates to isolated protein and to peptides which are found on the surface of colon cells and colon cancer cells, as well as to nucleic acid molecules encoding said protein and peptides. The protein and peptides bind to tumor-associated antibodies, such as mAb A33. The monomeric protein has a molecular weight of about 43 kD as determined by SDS gel electrophoresis under non-reducing conditions. In addition, this invention relates to the use of said nucleic acid molecules, protein, in monomeric or multimeric form, and to antibodies to said peptides in diagnostic, screening and therapeutic methods. This invention further relates to antibodies specific for said protein, in monomeric or multimeric form, and to antibodies to said peptides.